Search Results for "Latest news on OPY" OPYOppenheimer$90.02 -1.44 (-1.57%) Closing price 11/12/2026 03:59 PM EasternExtended Trading$89.64 -0.38 (-0.42%) As of 11/12/2026 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ExchangeNYSESectorFinanceIndustryCapital MarketsMarket Capitalization$979.54 millionP/E Ratio12.12Consensus RatingBuyDividend Yield0.87%View Full ProfileNewsStock ForecastEarningsDividendsInsider TradesInstitutional OwnershipSEC FilingsCompetitorsEarnings Jan 29Dividend 0.89%AI OverviewBetaAI-generated. Verify before making investment decisions.Loading the AI overviewRelated searchesOPY earningsOPY analyst price targetOPY dividend historyAll Search Results16 resultsTop ResultsArticles (16)Instant Alerts (20)ShowRelevanceDateSort byOppenheimer (NYSE:OPY) News and TrendsOppenheimer (NYSE:OPY) Stock Price, News & AnalysisReal-time quote, price history, analyst ratings, news and financial statements for Oppenheimer.Stock Forecast & Price TargetAnalyst consensus rating, twelve-month price targets and recent upgrades and downgrades.Earnings Date, Estimates & HistoryNext report date, EPS and revenue estimates, and the history of beats and misses.Dividend History & YieldDividend yield, payout history, ex-dividend dates and payout ratio.Insider Buying and SellingForm 4 filings from officers and directors with transaction dates and post-transaction holdings. Opko Health (NASDAQ: OPK) Stock: Multiple Expansion Breakout FormingDiversified healthcare company Opko Health (NASDAQ: OPK) shares have recently surged to 2018 highs at $6.47 from lows of $1.12 pandemic lows when the S&P 500 index (NYSEARCA: SPY) plunged (-34%) into March 2020.By Jea Yu·August 14, 2020OPKO Health is the Little Giant of Diversified Healthcare Diversified healthcare company OPKO Health Inc. (NASDAQ: OPK) shares may be low priced, but its businesses pipeline of treatments and upside potential mayBy Jea Yu·July 19, 2023 Coty (NYSE: COTY) Shares Are Re-Gaining MomentumBeauty products and fragrance maker Coty, Inc. (NYSE: COTY) stock has been in a treacherous multi-year slide further accelerated by the COVID-19 pandemic in 2020.By Jea Yu·November 18, 2020Mobileye's High Short Interest Signals Squeeze PotentialMobileye is well-positioned within the autonomous driving industry and can take share while deepening penetration with OEMs globally.By Thomas Hughes·January 22, 2025The Coty turnaround can accelerate in 2024Global beauty products maker Coty Inc. has been in a turnaround that looks to accelerate in 2024 as the company rides the medicated beauty trendBy Jea Yu·January 23, 2024Okta Stock is Digging Itself a BottomEnterprise identity solutions provider Okta (NASDAQ: OKTA) stock has been on a nasty downtrend since peaking out at $294 in February 2021.By Jea Yu·April 3, 2022Buy Chewy Inc. (CHWY) Stock Because It Won’t Stay DownOnline pet care supplier Chewy, Inc. (NASDAQ: CHWY) shares have been resilient throughout the coronavirus pandemic market sell-off of 2020.By Jea Yu·April 3, 2020OXY Stock Rebound Begins Following Solid Earnings BeatOccidental Petroleum is overcoming obstacles and effectively reducing costs. The margin is widening, and cash flow sustains a robust outlook for shareholders.By Thomas Hughes·May 9, 2025 Coty Stock Providing Pullback Opportunities Beauty products and fragrance maker Coty, Inc. (NYSE: COTY) stock is finally reversing the monthly downtrend that started in 2020 and further accelerated by the pandemic.By Jea Yu·February 18, 2021Occidental Petroleum Pulls Back To The Sweet SpotOccidental Petroleum pulled back to the sweet spot ahead of earnings and is now moving higher, the question is if Warren Buffet is buying now or not.By Thomas Hughes·February 28, 2023Occidental Petroleum stock price is ready to gush higherOccidental Petroleum is executing plans to reduce debt, free cash flow, and return capital to investors through dividend growth and repurchases.By Thomas Hughes·February 15, 2024Occidental Petroleum Will Move Higher in 2025 Say AnalystsOccidental Petroleum builds shareholder equity while paying down debt and a substantial dividend. Worth nearly 2% in mid-February, this distribution will grow.By Thomas Hughes·Updated February 26, 2025Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?Occidental Petroleum hit a 52-week low in March and may move lower, but investors shouldn't rush to the exits; Berkshire will probably buy more this month.By Thomas Hughes·March 6, 20255 Best Short-Term Stocks to Consider Investing InLooking for the best short-term stocks? Explore our top picks and learn how to navigate the risks and opportunities in fast-paced stock trading.By Dan Schmidt·July 10, 2024Oppenheimer (NYSE:OPY) Stock Crosses Below 200 Day Moving Average - What's Next?Oppenheimer (NYSE:OPY) Shares Break Below 200 Day Moving Average - What's Next?Alert·October 31, 2026Oppenheimer (NYSE:OPY) Downgraded by Wall Street Zen to "Hold"Wall Street Zen lowered shares of Oppenheimer from a "buy" rating to a "hold" rating in a report on Saturday.Alert·October 31, 2026Oppenheimer (NYSE:OPY) Shares Gap Up - Here's WhyOppenheimer (NYSE:OPY) Shares Gap Up - What's Next?Alert·November 4, 2026Oppenheimer (NYSE:OPY) Stock Falls 14.4% - Should You Sell?Oppenheimer (NYSE:OPY) Shares Down 14.4% - What's Next?Alert·October 30, 2026OPKO Health (NASDAQ:OPK) Hits New 12-Month High Following Analyst UpgradeOPKO Health (NASDAQ:OPK) Reaches New 12-Month High After Analyst UpgradeAlert·October 16, 2026Occidental Petroleum (OXY) Projected to Announce Earnings on MondayOccidental Petroleum (NYSE:OXY) will be releasing its Q3 2026 earnings after the market closes on Monday, November 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-11-9-occidental-petroleum-co-stock/)Alert·November 2, 2026FY2026 EPS Estimates for OPKO Health Raised by HC WainwrightOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities researchers at HC Wainwright increased their FY2026 earnings per share estimates for shares of OPKO Health in a report released on Thursday, November 5th. HC Wainwright analyst Y. Chen now expects that the biotechnology company will earn ($0.18Alert·November 9, 2026Zacks Research Issues Pessimistic Forecast for OXY EarningsOccidental Petroleum Co. (NYSE:OXY - Free Report) - Stock analysts at Zacks Research reduced their Q4 2024 EPS estimates for Occidental Petroleum in a research report issued on Tuesday, December 3rd. Zacks Research analyst J. Saha now anticipates that the oil and gas producer will post earnings oAlert·December 6, 2024Zacks Research Has Optimistic Outlook of OXY FY2024 EarningsOccidental Petroleum Co. (NYSE:OXY - Free Report) - Investment analysts at Zacks Research raised their FY2024 earnings per share estimates for shares of Occidental Petroleum in a research note issued on Thursday, January 30th. Zacks Research analyst J. Saha now expects that the oil and gas producAlert·Updated February 6, 2025Occidental Petroleum (OXY) to Release Earnings on TuesdayOccidental Petroleum (NYSE:OXY) will be releasing earnings after the market closes on Tuesday, February 18, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=654580)Alert·Updated February 14, 2025Polestar Lives to Fight Another Day After Q2 EarningsPolestar Automotive showed improvement in its latest earnings release, but it needs to show sustained progress. The company's new product might help.By Leo Miller·August 30, 2024Chewy (NASDAQ: CHWY) Stock Forming the Next Leg Melt UpOnline pet products and services platform Chewy, Inc. (NASDAQ: CHWY) shares have proven it to be a pandemic benefactor through the COVID-19 isolation mandates.By Jea Yu·June 18, 2020Occidental Petroleum (NYSE:OXY) Share Price Breaks Below Two Hundred Day Moving Average - What's Next?Occidental Petroleum (NYSE:OXY) Stock Price Breaks Below Two Hundred Day Moving Average - Should You Sell?Alert·November 10, 2026The Goldman Sachs Group Issues Positive Forecast for Occidental Petroleum (NYSE:OXY) Stock PriceThe Goldman Sachs Group raised their target price on shares of Occidental Petroleum from $69.00 to $76.00 and gave the company a "buy" rating in a research report on Tuesday.Alert·October 27, 2026Occidental Petroleum Corporation $OXY Shares Sold by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. cut its stake in shares of Occidental Petroleum Corporation (NYSE:OXY - Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,659,317 shares ofAlert·November 3, 2026OPKO Health (NASDAQ:OPK) Sets New 1-Year High - Still a Buy?OPKO Health (NASDAQ:OPK) Hits New 1-Year High - What's Next?Alert·November 3, 2026Occidental Petroleum (NYSE:OXY) Stock Sees Heavy Call Option BuyingOccidental Petroleum Corporation (NYSE:OXY - Get Free Report) saw unusually large options trading on Friday. Stock traders bought 96,009 call options on the stock. This is an increase of approximately 121% compared to the average volume of 43,480 call options.Alert·October 17, 2026Oatly Group AB Sponsored ADR (NASDAQ:OTLY) Stock Has Consensus Target Price of $14.31 According to BrokeragesShares of Oatly Group AB Sponsored ADR (NASDAQ:OTLY - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has given a holdAlert·October 29, 2026OPKO Health (NASDAQ:OPK) Director John Paganelli Sells 9,175 Shares of Company StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) Director John Paganelli sold 9,175 shares of the firm's stock in a transaction on Thursday, November 5th. The shares were sold at an average price of $1.82, for a total transaction of $16,698.50. Following the completion of the sale, the director...Alert·November 5, 2026Occidental Petroleum (NYSE:OXY) Stock Price Up 2.3% After Dividend AnnouncementOccidental Petroleum (NYSE:OXY) Shares Up 2.3% Following Dividend AnnouncementAlert·November 6, 2024OPKO Health (NASDAQ:OPK) Shares Gap Up - What's Next?OPKO Health (NASDAQ:OPK) Shares Gap Up - Time to Buy?Alert·October 15, 2026OPKO Health (NASDAQ:OPK) Shares Down 4.4% - What's Next?OPKO Health (NASDAQ:OPK) Stock Falls 4.4% - Time to Sell?Alert·November 11, 2026These results are filtered by type. Click here to see all results.OPYOppenheimer$90.02 -1.44 (-1.57%) Closing price 11/12/2026 03:59 PM EasternExtended Trading$89.64 -0.38 (-0.42%) As of 11/12/2026 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ExchangeNYSESectorFinanceIndustryCapital MarketsMarket Capitalization$979.54 millionP/E Ratio12.12Consensus RatingBuyDividend Yield0.87%View Full ProfileOPY NewsOppenheimer (NYSE:OPY) Shares Gap Up - Here's WhyNov 4, 2026 · AlertOppenheimer (NYSE:OPY) Downgraded by Wall Street Zen to "Hold"Oct 31, 2026 · AlertOppenheimer (NYSE:OPY) Stock Crosses Below 200 Day Moving Average - What's Next?Oct 31, 2026 · AlertAll OPY newsOPY Quick LinksNewsStock ForecastEarningsDividendsInsider TradesInstitutional OwnershipSEC FilingsCompetitorsOppenheimer MarketRank™ Stock Analysis1.95899921404 of 5 starsOverall MarketRank™39th Percentile Analyst RatingBuy Upside/DownsideN/A Short Interest LevelHealthy Dividend StrengthWeak News Sentiment0.22 Insider TradingN/A Proj. Earnings GrowthN/A See Full AnalysisOPY EarningsNext ReportJan 29, 2027, Before Market Opens (est.)Trailing EPS$7.43Earnings history & estimates Health Indicator for Oppenheimer TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 2 weeks, OPY's financial health has been in the Red zone, according to TradeSmith. Oppenheimer Dividend PaymentsDividend Yield0.89% Annual Dividend$0.80 Dividend Increase Track Record1 Year Annualized 5-Year Dividend Growth3.05% Dividend Payout Ratio10.77% Upcoming Ex-Dividend DateNov. 13 OPY Dividend HistoryRecent Analyst RatingsWall Street Zen10/31/2026DowngradeHoldWall Street Zen8/1/2026UpgradeBuyWall Street Zen5/9/2026DowngradeHoldWall Street Zen3/7/2026UpgradeStrong-BuyWall Street Zen11/8/2025DowngradeBuyAll OPY analyst ratingsInsider ActivityDennis P Mcnamara Insider3/2/2026Sell4,673 shares$423.70 thousandDennis P Mcnamara Insider8/5/2025Sell2,000 shares$147.62 thousandPaul M Friedman Director6/9/2025Sell3,500 shares$221.62 thousandDennis P Mcnamara Insider7/31/2024Sell6,000 shares$307.68 thousandAll OPY insider tradesRelated CompaniesBULLWebull$4.84-1.73%ETOReToro Group$22.03-5.51%TOPTOP Financial Group$14.47-8.42%PWPPerella Weinberg Partners$13.73-4.68%LCLNLCLNLincoln International$26.85-0.44%See all competitorsGet Oppenheimer alertsSign Up Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
